Header cover image

Italian Pharmaceuticals & Biotech Sustainable Track Record

Results

1

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

Philogen

Market Cap: €958.7m

A biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union.

PHIL

€23.80

7D

2.8%

1Y

8.2%